Advertisement

Topics

Cooper to acquire Teva’s contraceptive brand Paragard for $1.1bn

02:32 EDT 12 Sep 2017 | Medical Business Review

US-based medical device firm The Cooper Companies has agreed to buy Paragard, an intrauterine copper contraceptive brand from Teva Pharmaceutical Industries for $1.1bn in an all cash-deal.

Original Article: Cooper to acquire Teva’s contraceptive brand Paragard for $1.1bn

NEXT ARTICLE

More From BioPortfolio on "Cooper to acquire Teva’s contraceptive brand Paragard for $1.1bn"

Quick Search
Advertisement
 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...